Liuyang, China
The Hunan Provincial Government is partnering with Microbix Biosystems to construct an influenza vaccine manufacturing complex in the Hunan Liuyang Biomedical Industrial Park in China. The $200-million jointly-owned project, one of the largest flu vaccine production facilities worldwide, will be managed by Microbix and will utilize the company’s VIRUSMAX technology.
